
BioSnap provides cutting-edge AI solutions for laboratories and pharmaceutical facilities, specializing in sterile environment automation. Their core products include the BioSnapper, a device for revolutionizing sampling procedures with accurate sampling and seamless integration, and BioSnapshot, a companion beacon for data gathering, real-time monitoring, data collection, and advanced analytics. BioSnap focuses on innovation, precision, and efficiency, using TinyML for eco-friendly and low-powered AI applications. They also offer specialized project and R&D services for customized solutions. BioSnap aims to enhance sampling processes, ensuring reliability, precision, and efficiency while maintaining compliance with force and timing requirements.

BioSnap provides cutting-edge AI solutions for laboratories and pharmaceutical facilities, specializing in sterile environment automation. Their core products include the BioSnapper, a device for revolutionizing sampling procedures with accurate sampling and seamless integration, and BioSnapshot, a companion beacon for data gathering, real-time monitoring, data collection, and advanced analytics. BioSnap focuses on innovation, precision, and efficiency, using TinyML for eco-friendly and low-powered AI applications. They also offer specialized project and R&D services for customized solutions. BioSnap aims to enhance sampling processes, ensuring reliability, precision, and efficiency while maintaining compliance with force and timing requirements.
Sector: Embedded AI for sterile lab and pharmaceutical process automation
Core products: BioSnapper (sampling device); BioSnapshot (data-gathering beacon)
Location: San Juan, Puerto Rico (1250 Ave. Ponce de Leon Ste 301)
Early funding: Pre-Seed and Grant recorded on 2024-06-18
Notable investor/supporter: Parallel18
Automating sterile-environment sampling and process monitoring to meet compliance and operational requirements.
Biotechnology
20000
40000
“Parallel18 support (Pre-Seed and Grant recorded)”